You are viewing the site in preview mode

Skip to main content

Table 2 Baseline characteristics of 225 couples from the EARTH study in relation to male smoking status

From: Discrete survival model analysis of a couple’s smoking pattern and outcomes of assisted reproduction

  Male Smoking Status P –value
Never smoker Former smoker Current smoker
Number of couples, n (%) 154 (68.4) 55 (24.4) 16 (7.1) <0.001
Total ART cycles, n (%) 235 (66.4) 89 (25.1) 30 (8.5) <0.001
Male Characteristics b
 Age, years 35 (32, 40) 37 (34, 40) 37 (33, 39) 0.20
 BMI, kg/m2 26.8 (24.3, 29.1) 27.4 (24.3, 30.0) 25.6 (23.4, 28.3) 0.33
 At least college education, n (%) 111 (72.1) 33 (60.0) 7 (56.3) 0.15
 Non-Hispanic Caucasian, n (%) 137 (89.0) 48 (87.3) 13 (81.3) 0.58
 Pack-years NA 3.3 (1.1, 7.3) 7.0 (3.3, 8.7) 0.07
 Total smoking duration, years NA 10 (5, 14) 17 (14, 19) 0.001
 Average cigarettes smoked NA 6.0 (3.0, 12.0) 9.3 (4.8, 11.3) 0.68
 Age of smoking initiation, years NA 18 (16, 20) 16 (15, 20) 0.22
 Total Smoking cessation, years NA 4.0 (1.5, 7.8) 0.2 (0.2, 0.2) <0.001
 Exposed to passive smoking, n (%) 24 (15.6) 14 (25.5) 7 (43.8) 0.01
Male Reproductive History
 History of cryptorchidism, n (%) 10 (6.5) 2 (3.7) 2 (12.5) 0.42
 History of varicocele, n (%) 16 (10.4) 4 (7.3) 2 (12.5) 0.90
 History of reproductive surgery, n (%) 31 (20.1) 8 (14.6) 7 (43.8) 0.04
Female Partner Characteristics
 Partner age, years 34 (32, 38) 35 (33, 38) 36 (33, 39) 0.47
 Partner BMI, kg/m2 22.2 (20.7, 25.4) 23.8 (21.3, 27.7) 24.8 (20.5, 29.2) 0.11
 Partner former smoker, n (%) 31 (20.1) 16 (29.1) 4 (25.0) 0.38
 Partner current smoker, n (%) 2 (1.3) 1 (1.8) 4 (25.0) <0.001
Baseline Reproductive Characteristics
 Previous IUI, n (%) 67 (43.5) 18 (32.7) 7 (43.8) 0.37
 Previous IVF, n (%) 34 (77.9) 11 (20.0) 4 (25.0) 0.90
 ICSI, n (%) 82 (53.3) 27 (49.1) 9 (56.3) 0.83
 Infertility diagnosis, n (%)     0.53
  Male factor 55 (35.7) 16 (29.1) 8 (50.0)  
  Diminished ovarian reserve 8 (5.2) 3 (5.5) 2 (12.5)  
  Endometriosis 6 (3.9) 6 (10.9) 1 (6.3)  
  Ovulatory dysfunction 13 (8.4) 7 (12.7) 0 (0.0)  
  Tubal Causes 13 (8.4) 5 (9.1) 2 (12.5)  
  Uterine Causes 2 (1.3) 1 (1.8) 0 (0.0)  
  Unexplained 57 (37.0) 17 (30.9) 3 (18.8)  
 Initial treatment protocol, n (%)     0.05
  Antagonist 16 (10.4) 5 (9.1) 6 (37.5)  
  Flare 18 (11.7) 5 (9.1) 2 (12.5)  
  Luteal phase agonist 120 (77.9) 45 (82.8) 8 (50.0)  
 Day 3 FSH levels, IU/L 6.7 (5.8, 8.0) 6.6 (5.8, 8.2) 8.2 (7.3, 9.5) 0.004
 E2 Trigger levels, pmol/L 2076 (1560, 2678) 2145 (1632, 2570) 1761 (1225, 2311) 0.27
 Day of embryo transfer, n (%)     0.90
  No transfer 12 (7.8) 2 (7.3) 1 (6.3)  
  Day 2 7 (4.6) 1 (1.8) 1 (6.3)  
  Day 3 71 (46.4) 29 (52.7) 9 (56.3)  
  Day 5 63 (41.2) 21 (38.2) 5 (31.3)  
 Number of embryos transferred, n (%)     0.90
  No transfer 12 (7.8) 2 (7.3) 1 (6.3)  
  1 embryo 34 (22.2) 8 (14.6) 4 (25.0)  
  2 embryos 83 (54.3) 34 (61.8) 8 (50.0)  
  3 or more embryos 24 (15.7) 9 (16.4) 3 (18.8)  
  1. aFrom Chi square or Fisher test for discrete variables and Kruskal-Wallis for continuous variables
  2. bContinuous variables are presented as median (25th percentile, 75th percentile) while categorical variables are presented as number of women (percent)
  3. Abbreviations: ART Assisted reproductive technology, BMI Body mass index, E2 estradiol, FSH Follicle stimulating hormone, IVF In-vitro fertilization, ICSI Intracytoplasmic sperm injection, IUI Intrauterine sperm insemination